RecruitingNot ApplicableNCT06865066

Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety

Developing an Internet-Delivered Cognitive Behaviour Therapy Program for Women with Perimenopausal Anxiety: a Feasibility and Acceptability Study


Sponsor

Dr. Nazanin Alavi

Enrollment

25 participants

Start Date

Nov 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to design an online Cognitive Behavioural Therapy (CBT) and Acceptance Commitment Therapy (ACT) program and to learn if it can treat anxiety in women transitioning into menopause (perimenopause). The main questions it aims to answer are: * Is our online psychotherapy program a practical and acceptable means of managing anxiety during perimenopause? * Does our online psychotherapy program work in improving anxiety levels during perimenopause? Participants will participate in weekly e-CBT module sessions tailored to perimenopausal anxiety and will be given weekly feedback on assignments from trained care providers through a secure online platform. Participants will complete questionnaires at the beginning, middle, and at end of the study, as well as at the three and six-month follow-up.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years

Inclusion Criteria6

  • In perimenopausal staging (as defined by the STRAW +10 criteria)
  • Assigned female at birth
  • Diagnosis of GAD according to DSM-5 by attending psychiatrist on research team
  • Competence to consent to participate
  • Ability to speak and read English
  • Consistent and reliable access to the internet

Exclusion Criteria5

  • Undergone CBT or hormone therapy within the last 6 months will be excluded
  • Active psychosis
  • Acute mania
  • Severe alcohol or substance use disorder
  • Active suicidal or homicidal ideation

Interventions

BEHAVIORALe-CBT

Electronically delivered cognitive behavioural therapy with acceptance commitment therapy components


Locations(2)

Kingston General Hospital

Kingston, Ontario, Canada

Nazanin Alavi

Kingston, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06865066


Related Trials